These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8170717

  • 1. [Anatomo-pathologic diagnostic interpretation of nodular hepatic lesions].
    Chiaramondia M, Ceppa P, Baccini P, Badini A, Castellaneta A.
    Pathologica; 1993; 85(1100):687-99. PubMed ID: 8170717
    [Abstract] [Full Text] [Related]

  • 2. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
    Tang W, Guo Q, Qu X, Inagaki Y, Seyama Y, Midorikawa Y, Gai R, Kokudo N, Sugawara Y, Nakata M, Makuuchi M.
    Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
    [Abstract] [Full Text] [Related]

  • 3. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
    Fucich LF, Cheles MK, Thung SN, Gerber MA, Marrogi AJ.
    Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
    [Abstract] [Full Text] [Related]

  • 4. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM.
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Localisation of hepatic lesions to liver segments according to sonography (US), computed tomography (CT) and surgery (OP): a comparative study].
    Schacherer D, Decking D, Herold T, Obed A, Schlitt HJ, Gruene S, Schoelmerich J, Schlottmann K.
    Z Gastroenterol; 2010 Feb; 48(2):241-5. PubMed ID: 20127599
    [Abstract] [Full Text] [Related]

  • 11. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL, Das KM, Fogt F, Burke M, Murakata LA.
    Oncol Rep; 2002 Feb; 9(6):1369-72. PubMed ID: 12375050
    [Abstract] [Full Text] [Related]

  • 12. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C, Herlea V, Dragnea A, Popescu I.
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers.
    Porcell AI, De Young BR, Proca DM, Frankel WL.
    Mod Pathol; 2000 Jul; 13(7):773-8. PubMed ID: 10912937
    [Abstract] [Full Text] [Related]

  • 14. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK, Prakash S, Geller SA, Alsabeh R.
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sarcomatous cholangiocarcinoma.
    Gupta K, Powari M, Dey P.
    Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.